McKnight's Long-Term Care News37m
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
FDA approves medication for sleep apnea
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
The American Spectator2h
Trump: Look at the Slow-Moving FDA
The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...
NeuroPace's SWOT analysis: epilepsy device maker's stock poised for growth
NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy ...
Ticker: FDA puts out alarming chocolate recall; Tesla’s fourth-quarter results fall short; Meta posts sharply higher Q4 profit
Ticker: FDA puts out alarming chocolate recall; Tesla’s fourth-quarter results fall short; Meta posts sharply higher Q4 ...
Hosted on MSN4h
Phase III Trials: It’s crunch time for these ASX health stocks
Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...
The National Law Review9h
FDA Develops Strategy to Prevent Adulteration of Berries with Enteric Viral Infections
FDA released a summary of a strategy intended to prevent human norovirus and hepatitis A virus (HAV) outbreaks associated ...
Lay’s recall upgraded to highest risk level
The Food and Drug Administration (FDA) says a previously announced recall of certain bags of Lay’s potato chips in Oregon and ...